Anti-PGC1 alpha + beta抗體,過氧化物酶體增殖物激活受體γ輔激活子1α+β抗體產品經無數次市場驗證，若出現質量問題可無條件換貨或退貨,詳細信息：

產品詢價 或（成）客服

英文名稱 PGC1 alpha + beta
抗體名稱 Anti-PGC1 alpha + beta抗體,過氧化物酶體增殖物激活受體γ輔激活子1α+β抗體
別    名 LEM6; Ligand effect modulator 6; PERC; Peroxisome proliferative activated receptor, gamma, coactivator 1 alpha; Peroxisome proliferative activated receptor, gamma, coactivator 1; Peroxisome proliferator activated receptor gamma coactivator 1 alpha; peroxisome proliferator-activated receptor gamma coactivator 1 beta; Peroxisome proliferator-activated receptor gamma coactivator 1-alpha; Peroxisome proliferator-activated receptor gamma coactivator 1-beta; peroxisome proliferator-activated receptor gamma, coactivator 1 beta; PGC 1 (alpha); PGC 1 alpha; PGC 1v; PGC-1(beta); PGC-1-alpha; PGC-1-beta; PGC-1-related estrogen receptor alpha coactivator; PGC1; PGC1(alpha); PGC1A; PGC1v; PPAR gamma coactivator 1 alpha; PPAR gamma coactivator 1 alpha 3 ligand effect modulator 6; PPAR gamma coactivator 1; PPAR gamma coactivator variant form; PPAR gamma coactivator-1beta; PPAR-gamma coactivator 1-alpha; PPAR-gamma coactivator 1-beta; PPARGC 1 alpha; PPARGC-1-alpha; PPARGC-1-beta; PPARGC1; PPARGC1A; Ppargc1b; PRGC1_HUMAN; PRGC2_HUMAN.  
研究領域 心血管  細胞生物  染色質和核信號  信號轉導  糖尿病  表觀遺傳學  
抗體來源 Rabbit
克隆類型 Polyclonal
交叉反應 Human, Mouse, Rat, Dog, Pig, Cow, Horse, Rabbit, 
產品應用 WB=1:100-500 ELISA=1:500-1000 IHC-P=1:200-800 IHC-F=1:100-500 IF=1:100-500 （石蠟切片需做抗原修復） 
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
分 子 量 88/113kDa
細胞定位 細胞核 
性    狀 Lyophilized or Liquid
濃    度 1mg/1ml
免 疫 原 KLH conjugated synthetic peptide derived from human PGC1 alpha + beta
亞    型 IgG
純化方法 affinity purified by Protein A
儲 存 液 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

Anti-PGC1 alpha + beta抗體,過氧化物酶體增殖物激活受體γ輔激活子1α+β抗體上海研盟生物其它優勢產品：

13085R Anti-phospho-Ephrin B(Ser287),磷酸化Ephrin B抗體
13086R Anti-EPLIN抗體,惡性腫瘤丟失蛋白EPLIN抗體
13089R Anti-Phospho-HER2(Tyr1139),磷酸化HER2受體抗體
13092R Anti-Phospho-HER3(Tyr1276),磷酸化HER3受體抗體
13093R Anti-Phospho-HER4(Tyr1258),磷酸化HER4抗體
13096R Anti-ERF抗體,轉錄因子ERF抗體
13097R Anti-phospho-ERF(Thr526),磷酸化轉錄因子ERF抗體
13098R Anti-eRF1抗體,真核肽鏈釋放因子1抗體
13100R Anti-EPS15R抗體,表皮生長因子受體底物15抗體
13101R Anti-Epsin 1抗體,內吞作用輔助蛋白EPN1抗體
13103R Anti-ERGI3抗體,內質網定位蛋白ERGI3抗體
13104R Anti-ERO1L抗體,內質網氧化物蛋白Ero1-Lα抗體
13105R Anti-ERp19抗體,內質網蛋白ERp19抗體
13106R Anti-ERp72抗體,內質網蛋白ERp72抗體
13107R Anti-ESAT6抗體,結核分枝桿菌分泌性蛋白ESAT6抗體
13108R Anti-ESRP2抗體,上皮粘連調控蛋白ESRP2抗體
13109R Anti-ETEA抗體,T細胞和嗜酸性粒細胞表達特應性皮炎蛋白ETEA抗體
13110R Anti-ETFDH抗體,電子轉移黃素蛋白脫氫酶抗體
13111R Anti-ETL抗體,EGF毒素受體7跨膜結構域蛋白1抗體
13112R Anti-ETNK2抗體,乙醇胺激酶2抗體

Anti-PGC1 alpha + beta抗體,過氧化物酶體增殖物激活受體γ輔激活子1α+β抗體抗體原理 
（1）特異性結合抗原：抗體本身不能直接溶解或殺傷帶有特異抗原的靶細胞，通常需要補體或吞噬細胞等共同發揮效應以清除病原微生物或導致病理損傷。然而，抗體可通過與病毒或毒素的特異性結合，直接發揮中和病毒的作用。 
（2）激活補體：IgM、IgG1、IgG2和IgG3可通過經典途徑激活補體，凝聚的IgA、IgG4和IgE可通過替代途徑激活補體。 
（3）結合細胞：不同類別的免疫球蛋白，可結合不同種的細胞，參與免疫應答。 
（4）可通過胎盤及粘膜：免疫球蛋白G（IgG）能通過胎盤進入胎兒血流中，使胎兒形成自然被動免疫。免疫球蛋白A（IgA）可通過消化道及呼吸道粘膜，是粘膜局部抗感染免疫的主要因素。 
（5）具有抗原性：抗體分子是一種蛋白質，也具有刺激機體產生免疫應答的性能。不同的免疫球蛋白分子，各具有不同的抗原性。 
（6）抗體對理化因子的抵抗力與一般球蛋白相同：不耐熱，60～70℃即被破壞。各種酶及能使蛋白質凝固變性的物質，均能破壞抗體的作用。抗體可被中性鹽類沉淀。在生產上常可用硫酸銨或硫酸鈉從免疫血清中沉淀出含有抗體的球蛋白，再經透析法將其純化。
產品介紹 The protein encoded by this gene is a transcriptional coactivator that regulates the genes involved in energy metabolism. This protein interacts with PPARgamma, which permits the interaction of this protein with multiple transcription factors. This protein can interact with, and regulate the activities of, cAMP response element binding protein (CREB) and nuclear respiratory factors (NRFs). It provides a direct link between external physiological stimuli and the regulation of mitochondrial biogenesis, and is a major factor that regulates muscle fiber type determination. This protein may be also involved in controlling blood pressure, regulating cellular cholesterol homoeostasis, and the development of obesity. 

運輸方面：現貨供應，一般為快遞運輸，江浙滬隔天到，外地及偏遠地方三至五天時間到貨。